In a groundbreaking move, Abbott has unveiled its revolutionary vascular imaging platform in India, equipped with Ultreon 1.0 Software. This pioneering intra-vascular imaging solution merges optical coherence tomography (OCT) with artificial intelligence (AI), offering clinicians an all-encompassing perspective of blood circulation and obstructions in the coronary arteries.

The cutting-edge software is adept at autonomously identifying calcified from non-calcified blockages, assessing the intensity of calcium-based obstructions, and ascertaining vessel diameter. It plays a crucial role in assisting medical professionals with the accurate deployment of stents, confirming ideal stent expansion, and alignment, while simultaneously showcasing the results. This precision is pivotal during coronary stenting procedures.

Abbott’s OCT technology diverges from conventional imaging techniques like angiography; it employs near-infrared light to produce sharp, detailed images from inside a blood vessel. This method is proficient in obtaining data from the most intricate patient anatomies. The software expedites an efficient workflow, promoting swift and accurate decision-making and minimising uncertainties, enabling physicians to concentrate on paramount patient care and enhancing their life quality.

The deployment of Ultreon 1.0 Software exemplifies Abbott’s commitment to harnessing OCT technology in assisting physicians in making superior treatment choices. Recent findings indicate a change in treatment approach in 88% of coronary artery blockages when physicians employed OCT with MLD MAX, a novel workflow that aids stenting decisions, furnishing doctors with strategies to perfect stent placement.

Dr. Ankur Phatarpekar of Symbiosis Speciality Hospital, Mumbai, comments, “This innovative OCT software presents an automated, extensive insight into coronary arteries, significantly aiding in making informed decisions and ensuring accurate stent positioning. Such advancements are vital in delivering optimal patient care.”

A market study initiated by Abbott, named Beyond Intervention, revealed in August 2020 that medical professionals and administrators view technology as essential in enhancing patient outcomes throughout the healthcare spectrum. The study highlighted that 83.2% of physicians acknowledge that progress in diagnostic and treatment technologies like OCT has led to notable patient care improvements.

Ultreon Software represents a technological evolution intended to bolster physician decision-making, especially when integrated with established instruments that offer a thorough physiological evaluation of coronary blood flow and the severity of blockages. Given the escalating prevalence of cardiovascular conditions in India, the introduction of innovative technologies is part of a continuous effort to equip physicians with necessary tools, ensuring superior care and outcomes for patients.

Tushar Sharma, the general manager for Abbott’s vascular business in India and South Asia, remarks, “The growing utilisation of OCT imaging, especially when amalgamated with sophisticated technology such as AI, provides cardiologists with a more accurate and quantifiable method to assist patients undergoing coronary stent procedures.”

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.